Arancio W, Belmonte B, Castiglia M, Di Napoli A, Tripodo C. Tissue Versus Liquid Biopsy: Opposite or Complementary?..Current Clinical Pathology. 2017:41-49. doi:10.1007/978-3-319-55661-1_4LOGO
Custom Panel Design For NGS | Twist Bioscience. Twistbioscience.com. https://www.twistbioscience.com/ blog/company-news-updates/Custom-Panel-Design- NGS. Published 2021. Accessed March 1, 2022.
Réda M, Richard C, Bertaut A et al. Implementation and use of whole exome sequencing for metastatic solid cancer..EBioMedicine. 2020;51:102624. doi:10.1016/j. ebiom.2019.102624
Pantel K, Alix-Panabières C. Liquid biopsy and minimal residual disease — latest advances and implications for cure. Nature Reviews Clinical Oncology. 2019;16(7):409-424. doi:10.1038/s41571-019-0187-3
Honoré N, Galot R, van Marcke C, Limaye N, Machiels J. Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact. Cancers (Basel). 2021;13(21):5364. doi:10.3390/cancers13215364
Parsons H, Rhoades J, Reed S et al. Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer. Clinical Cancer Research. 2020;26(11):2556-2564. doi:10.1158/1078-0432.ccr-19-3005